This paper is a systematic review of the treatment of bipolar disorder: a systematic Google Scholar search aimed at treatment guidelines and clinical trials. The search for treatment guidelines returned 375 papers and was last performed from June 1, 2022 to August 30, 2022. The literature suggests that lithium helps control and alleviate severe mood episodes, and olanzapine is effective for acute manic or mixed episodes of bipolar I disorder. Achieving effectiveness or remission is better with Cariprazine. Lurasidone improves cognitive performance. Quetiapine improves sleep quality and co-morbid anxiety. Lamotrigine helps delay depression, mania, and mild manic episodes. Antidepressants are best used in conjunction with mood stabilizers. For co-morbid treatment, carbamazepine and lithium in combination are more effective in the treatment of psychotic mania. Co-morbid anxiety treatment considers adjunctive olanzapine or lamotrigine. Co-morbid bulimia treatment considers a mood stabilizer. Co-morbid fatigue treatment considers a dawn simulator. For diet, pay attention to a healthy diet, patients can ingest probiotics and pay attention to the balance of fatty acids.
References
[1]
Akiskal, H.S., Hantouche, E.G. and Allilaire, J.F. (2003) Bipolar II with and without Cyclothymic Temperament: “Dark” and “Sunny” Expressions of Soft Bipolarity. Journal of Affective Disorder, 73, 49-57. https://doi.org/10.1016/S0165-0327(02)00320-8
[2]
Amerio, A., Russo, D., et al. (2021) Polypharmacy as Maintenance Treatment in Bipolar Illness: A Systematic Review. Acta Psychiatrica Scandinavica, 144, 259-276. https://doi.org/10.1111/acps.13312
[3]
Amsterdam, J.D., Lorenzo-Luaces, L., Soeller, I., et al. (2016) Short-Term Venlafaxine v. Lithium Monotherapy for Bipolar Type II Major Depressive Episodes: Effectiveness and Mood Conversion Rate. British Journal of Psychiatry, 208, 359-365. https://doi.org/10.1192/bjp.bp.115.169375
[4]
Zeng, C.R., Qiu, Y., Li, S.J., Teng, Z.W., Xiang, H., Chen, J.D., Wu, X.X., Cao, T., Zhang, S.Y., Chen, Q., Wu, H.S. and Cai. H.L. (2022) Effect of Probiotic Supplements on Oxidative Stress Biomarkers in First-Episode Bipolar Disorder Patients: A Randomized, Placebo-Controlled Trial. Frontiers in Pharmacology, 13, Article 829815.https://doi.org/10.3389/fphar.2022.829815
[5]
Calabrese, J.R., Bowden, C.L., Sachs, G., et al. (2003) A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients with Bipolar I Disorder. The Journal of Clinical Psychiatry, 64, 1013-1024. https://doi.org/10.4088/JCP.v64n0906 Carvalho, A.F., Firth, J. and Vieta, E. (2020) Bipolar Disorder. The New England Journal of Medicine, 383, 58-66. https://doi.org/10.1056/NEJMra1906193
[6]
Choi, J.H., Yates, Z., Veysey, M., Heo, Y.R. and Lucock, M. (2014) Contemporary Issues Surrounding Folic Acid for Tification Initiatives. Preventive Nutrition and Food Science, 19, 247-260. https://doi.org/10.3746/pnf.2014.19.4.247
[7]
Aiken, C. (2020) An Overview of Atypical Antipsychotics for Bipolar Depression. Psychiatric Times.
[8]
Clark, C.T., Klein, A.M., Perel, J.M., et al. (2013) Lamotrigine Dosing for Pregnant Patients with Bipolar Disorder. The American Journal of Psychiatry, 170, 1240-1247. https://doi.org/10.1176/appi.ajp.2013.13010006
[9]
Brown, E.S., Sunderajan, P., Hu, L.T., et al. (2012) A Randomized, Double-Blind, Placebo-Controlled, Trial of Lamotrigine Therapy in Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence. Neuropsychopharmacology, 37, 2347-2354. https://doi.org/10.1038/npp.2012.90
[10]
Danilenko, K.V. and Ivanova, I.A. (2015) Dawn Simulation vs. Bright Light in Seasonal Affective Disorder: Treatment Effects and Subjective Preference. Journal of Affective Disorders, 180, 87-89. https://doi.org/10.1016/j.jad.2015.03.055
[11]
Hilditch, C.J., Dorrian, J. and Banks, S. (2016). Time to Wake Up: Reactive Countermeasures to Sleep Inertia. Industrial Health, 54, 528-541. https://doi.org/10.2486/indhealth.2015-0236
[12]
Dickerson, F., Adamos, M., et al. (2018) Adjunctive Probiotic Microorganisms to Prevent Rehospitalization in Patients with Acute Mania: A Randomized Controlled Trial. Bipolar Disorders, 20, 614-621. https://doi.org/10.1111/bdi.12652
[13]
Gabriel, F.C., Oliveira, M., et al. (2022) Nutrition and Bipolar Disorder: A Systematic Review. Nutritional Neuroscience.
[14]
Fornaro, M., Anastasia, A., Novello, S., et al. (2018) Incidence, Prevalence and Clinical Correlates of Antidepressant-Emergent Mania in Bipolar Depression: A Systematic Review and Meta-Analysis. Bipolar Disorders, 20, 195-227. https://doi.org/10.1111/bdi.12612
[15]
Fornaro, M., Orsolini, L., Marini, S., et al. (2016) The Prevalence and Predictors of Bipolar and Borderline Personality Disorders Comorbidity: Systematic Review and Meta-Analysis. Journal of Affective Disorder, 195, 105-118. https://doi.org/10.1016/j.jad.2016.01.040
[16]
Geddes, J.R., Gardiner, A., Rendell, J., et al. (2016) Comparative Evaluation of Quetiapine plus Lamotrigine Combination versus Quetiapine Monotherapy (and Folic Acid versus Placebo) in Bipolar Depression (CEQUEL): A 2 × 2 Factorial Randomised Trial. Lancet Psychiatry, 3, 31-39. https://doi.org/10.1016/S2215-0366(15)00450-2
[17]
Goldberg, J.F., Bowden, C.L. and Calabrese, J.R. (2008) Six-Month Prospective Life Charting of Mood Symptoms with Lamotrigine Monotherapy versus Placebo in Rapid Cycling Bipolar Disorder. Biological Psychiatry, 63, 125-130. https://doi.org/10.1016/j.biopsych.2006.12.031
[18]
Goodwin, G.M., Haddad, P.M., Ferrier, I.N., et al. (2016) Evidence-Based Guidelines for Treating Bipolar Disorder: Revised Third Edition Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30, 495-553. https://doi.org/10.1177/0269881116636545
[19]
Harvey, A.G., Soehner, A.M., Kaplan, K.A., et al. (2015) Treating Insomnia Improves Mood State, Sleep, and Functioning in Bipolar Disorder: A Pilot Randomized Controlled Trial. Journal of Consulting and Clinical Psychology, 83, 564-577. https://doi.org/10.1037/a0038655
[20]
Dias, V.V., Balanzá-Martinez, V., Soeiro-de-Souza, M.G., et al. (2012) Pharmacological Approaches in Bipolar Disorders and the Impact on Cognition: A Critical Overview. Acta Psychiatrica Scandinavica, 126, 315-331. https://doi.org/10.1111/j.1600-0447.2012.01910.x
[21]
Kaplan, K.A., Talavera, D.C. and Harvey, A.G. (2018) Rise and Shine: A Treatment Experiment Testing a Morning Routine to Decrease Subjective Sleep Inertia in Insomnia and Bipolar Disorder. Behaviour Research and Therapy, 111, 106-112. https://doi.org/10.1016/j.brat.2018.10.009
[22]
Kikkawa, A., Kitamura, Y., Aiba, T., et al. (2017) Correlation between the Efficacy of Lamotrigine and the Serum Lamotrigine Level during the Remission Phase of Acute Bipolar II Depression: A Naturalistic and Unblinded Prospective Pilot Study. Biological and Pharmaceutical Bulletin, 40, 413-418. https://doi.org/10.1248/bpb.b16-00725
[23]
Kishi, T., Ikuta, T., et al. (2020) Mood Stabilizers and/or Antipsychotics for Bipolar Disorder in the Maintenance Phase: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Molecular Psychiatry, 26, 4146-4157. https://doi.org/10.1038/s41380-020-00946-6
[24]
Kotin, J. and Goodwin, F.K. (1972) Depression during Mania: Clinical Observations and Theoretical Implications. The American Journal of Psychiatry, 129, 679-786. https://doi.org/10.1176/ajp.129.6.679
[25]
Lieb, K., Völlm, B., Rücker, G., Timmer, A. and Stoffers, J.M. (2010) Pharmacotherapy for Borderline Personality Disorder: Cochrane Systematic Review of Randomised Trials. British Journal of Psychiatry, 196, 4-12. https://doi.org/10.1192/bjp.bp.108.062984
[26]
Maina, G., Albert, U., Rosso, G. and Bogetto, F. (2008) Olanzapine or Lamotrigine Addition to Lithium in Remitted Bipolar Disorder Patients with Anxiety Disorder Comorbidity: A Randomized, Single-Blind, Pilot Study. The Journal of Clinical Psychiatry, 69, 609-616. https://doi.org/10.4088/JCP.v69n0413
[27]
Manning, J.S., Haykal, R.F., Connor, P.D., Cunningham, P.D., Jackson, W.C. and Long, S. (2005) Sustained Remission with Lamotrigine Augmentation or Monotherapy in Female Resistant Depressives with Mixed Cyclothymic-Dysthymic Temperament. Journal of Affective Disorders, 84, 259-266. https://doi.org/10.1016/j.jad.2004.01.016
